Data Supplement from Cryotherapy with Concurrent CpG Oligonucleotide Treatment Controls Local Tumor Recurrence and Modulates HER2/neu Immunity

Supplementary Figure S2. BALB/c mice were inoculated with TUBO 3d before adoptive serum transfer of 25 µg equivalent α-neu Ab from mice previously treated with cryo + CpG or pNeuE2 vaccination, naïve control serum, or 25 µg monoclonal Ab4 (n=3-5) as a single tail vein injection in a total volume of 200 µL with PBS. TUBO tumor volume 30 days after inoculation. **P<0.01